News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,830 Results
Type
Article (70187)
Company Profile (277)
Press Release (651364)
Multimedia
Podcasts (130)
Webinars (19)
Section
Business (197368)
Career Advice (2861)
Deals (35026)
Drug Delivery (125)
Drug Development (84176)
Employer Resources (175)
FDA (16965)
Job Trends (15033)
News (343641)
Policy (34887)
Tag
Academia (2890)
Academic (1)
Accelerated approval (11)
Adcomms (32)
Allergies (101)
Alliances (51090)
ALS (119)
Alzheimer's disease (1562)
Antibody-drug conjugate (ADC) (184)
Approvals (16917)
Artificial intelligence (357)
Autoimmune disease (36)
Automation (14)
Bankruptcy (341)
Best Places to Work (11253)
BIOSECURE Act (22)
Biosimilars (134)
Biotechnology (152)
Bladder cancer (99)
Brain cancer (39)
Breast cancer (380)
Cancer (3024)
Cardiovascular disease (241)
Career advice (2399)
Career pathing (34)
CAR-T (204)
CDC (41)
Cell therapy (546)
Cervical cancer (23)
Clinical research (68714)
Collaboration (1084)
Company closure (3)
Compensation (703)
Complete response letters (33)
COVID-19 (2829)
CRISPR (67)
C-suite (344)
Cystic fibrosis (116)
Data (3042)
Decentralized trials (2)
Denatured (37)
Depression (75)
Diabetes (368)
Diagnostics (6415)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (155)
Drug pricing (149)
Drug shortages (35)
Duchenne muscular dystrophy (131)
Earnings (78136)
Editorial (48)
Employer branding (23)
Employer resources (155)
Events (108008)
Executive appointments (881)
FDA (18658)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (954)
Gene editing (144)
Generative AI (29)
Gene therapy (428)
GLP-1 (918)
Government (4602)
Grass and pollen (6)
Guidances (178)
Healthcare (18503)
HIV (43)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (179)
Immuno-oncology (10)
Indications (40)
Infectious disease (3020)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (67)
Intellectual property (122)
Interviews (525)
IPO (16361)
IRA (53)
Job creations (4181)
Job search strategy (2001)
Kidney cancer (14)
Labor market (49)
Layoffs (574)
Leadership (26)
Legal (8489)
Liver cancer (85)
Longevity (12)
Lung cancer (430)
Lymphoma (214)
Machine learning (11)
Management (62)
Manufacturing (426)
MASH (98)
Medical device (12923)
Medtech (12928)
Mergers & acquisitions (19410)
Metabolic disorders (950)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (139)
Neuropsychiatric disorders (41)
Neuroscience (2303)
NextGen: Class of 2025 (6335)
Non-profit (4646)
Now hiring (43)
Obesity (491)
Opinion (277)
Ovarian cancer (103)
Pain (117)
Pancreatic cancer (124)
Parkinson's disease (198)
Partnered (22)
Patents (310)
Patient recruitment (164)
Peanut (54)
People (58324)
Pharmaceutical (97)
Pharmacy benefit managers (25)
Phase I (21256)
Phase II (29848)
Phase III (22853)
Pipeline (1681)
Policy (239)
Postmarket research (3011)
Preclinical (9444)
Press Release (71)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (265)
Rare diseases (517)
Real estate (6234)
Recruiting (71)
Regulatory (24484)
Reports (41)
Research institute (2636)
Resumes & cover letters (470)
Rett syndrome (10)
RNA editing (9)
RSV (56)
Schizophrenia (98)
Series A (165)
Series B (111)
Service/supplier (20)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (37)
Startups (3661)
State (2)
Stomach cancer (17)
Supply chain (81)
Tariffs (65)
The Weekly (91)
Vaccines (905)
Venture capital (57)
Weight loss (331)
Women's health (46)
Worklife (20)
Date
Today (73)
Last 7 days (394)
Last 30 days (1945)
Last 365 days (32252)
2025 (17516)
2024 (35967)
2023 (40503)
2022 (51598)
2021 (55857)
2020 (53812)
2019 (45865)
2018 (34706)
2017 (33986)
2016 (33810)
2015 (38729)
2014 (32400)
2013 (28455)
2012 (29866)
2011 (30330)
2010 (28897)
Location
Africa (971)
Alabama (66)
Alaska (7)
Arizona (226)
Arkansas (13)
Asia (44265)
Australia (7597)
California (7442)
Canada (2292)
China (702)
Colorado (324)
Connecticut (341)
Delaware (201)
Europe (101026)
Florida (1127)
Georgia (242)
Hawaii (2)
Idaho (59)
Illinois (651)
India (29)
Indiana (341)
Iowa (17)
Japan (235)
Kansas (105)
Kentucky (30)
Louisiana (14)
Maine (69)
Maryland (1053)
Massachusetts (5612)
Michigan (247)
Minnesota (451)
Mississippi (2)
Missouri (87)
Montana (28)
Nebraska (24)
Nevada (76)
New Hampshire (60)
New Jersey (2118)
New Mexico (28)
New York (2112)
North Carolina (1153)
North Dakota (9)
Northern California (3274)
Ohio (231)
Oklahoma (14)
Oregon (36)
Pennsylvania (1575)
Puerto Rico (17)
Rhode Island (34)
South America (1336)
South Carolina (35)
South Dakota (1)
Southern California (2780)
Tennessee (122)
Texas (1107)
United States (27785)
Utah (205)
Virginia (198)
Washington D.C. (78)
Washington State (646)
West Virginia (4)
Wisconsin (80)
721,830 Results for "apr applied pharma research s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research
June 25, 2025
·
2 min read
Press Releases
Preclinical Data on Circle Pharma’s CID-078 Featured in Poster Presentation at Advances in Neuroblastoma Research Meeting
May 27, 2025
·
3 min read
Press Releases
Mitsubishi Research Institute and Astellas Announce Collaboration to Support Pharma Startups in Japan
June 13, 2025
·
4 min read
Press Releases
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
June 17, 2025
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America Highlights Parkinson’s Disease Research at 2025 EAN and ATMRD Congresses
June 23, 2025
·
4 min read
Tariffs
Trump’s Tariffs Could Challenge Pharma’s Recession-Resistant Reputation
Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.
April 8, 2025
·
5 min read
·
Annalee Armstrong
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
As of Apr. 22, Sage had 338 full-time employees, all of whom will be laid off effective Aug. 22. The layoffs were announced a few weeks after Maryland’s Supernus Pharmaceuticals acquired Sage for up to $795 million.
June 30, 2025
·
1 min read
·
Tristan Manalac
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Outcome of Innate Pharma’s 2025 Annual General Meeting
May 23, 2025
·
5 min read
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
1 of 72,183
Next
